A collagen binding assay: an additional method for von Willebrand factor activity in therapeutic concentrates
Neugebauer, B.M.; Goy, C.; Seitz, R.
Thrombosis and Haemostasis 88(5): 871-872
2002
ISSN/ISBN: 0340-6245 PMID: 12428108 Document Number: 544005
Document emailed within 1 workday
Related Documents
Mazurier, C.; Meyer, D. 1996: Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 76(2): 270-274Fricke, W.A.; Lamb, M.A.; Rastogi, S.C. 1993: Standards for assay of von Willebrand factor concentrates: a collaborative study Thrombosis and Haemostasis 70(2): 351-356
Escolar, G.; Carretero, M.; Magallón, M.; Quintana, M.; Arnau, C.; Castillo, R.; Aznar-Salatti, J. 1998: von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease Haematologica 83(11): 1009-1014
Rosén, S. 2001: A rebuttal: Issues with the assay of factor VIII activity in plasma and factor VII concentrates Thrombosis and Haemostasis 86(4): 1132-1133
Chang, P.; Aronson, D.L. 1997: Plasma derived von Willebrand factor preparations: collagen binding and ristocetin cofactor activities Thrombosis and Haemostasis 78(2): 930-933
Lu, G-yuan.; Shen, L.; Wang, Z-yue.; Guo, X-fang.; Bai, X.; Su, J.; Ruan, C-geng. 2008: Significance of plasma von Willebrand factor level and von Willebrand factor-cleaving protease activity in patients with chronic renal diseases Chinese Medical Journal 121(2): 133-136
Rastegar-Lari, G.; Ajzenberg, N.; Ribba, A.S.; Vereycken-Holler, V.; Legendre, P.; Villoutreix, B.; Meyer, D.; Baruch, D. 2001: Defect of heparin binding in plasma and recombinant von Willebrand factor with type 2 von Willebrand disease mutations Thrombosis and Haemostasis 86(6): 1459-1465
Inbal, A.; Kornbrot, N.; Harrison, P.; Randi, A.M.; Sadler, J.E. 1993: Effect of type IIB von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein Ib binding--studies with recombinant von Willebrand factor Thrombosis and Haemostasis 70(6): 1058-1062
Orthner, C.L. 1984: Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography Journal of Laboratory and Clinical Medicine 104(5): 816-828
Shibata, M.; Shima, M.; Fujimura, Y.; Takahashi, Y.; Nakai, H.; Sakurai, Y.; Asatani, M.; Nomura, A.; Take, H.; Giddings, J.C.; Yoshioka, A. 1999: Identification of the binding site for an alloantibody to von Willebrand factor which inhibits binding to glycoprotein Ib within the amino-terminal region flanking the A1 domain Thrombosis and Haemostasis 81(5): 793-798
Green, D.; Muller, H.P. 1978: Platelet-binding of the von Willebrand factor Thrombosis and Haemostasis 39(3): 689-694
Hofmann, V.; Ermanni, M.; Straub, P.W. 1978: Thrombin formation in factor IX concentrates and FEIBA (factor eight inhibitor bypassing activity) (proceedings) Schweizerische Medizinische Wochenschrift 108(41): 1600
Allain, J.P. 1972: Study of the "in vivo" activity of factor VIIi or factor IX after injection of several concentrates: practical applications Nouvelle Revue Francaise d'Hematologie 12(2): 241-249
Takahashi, H.; Sakuragawa, N.; Shibata, A. 1979: Studies on the assay of the plasma factor XIIi activity with dansylcadaverine incorporation method Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 42(3): 516-524
Silverman, C.; Mascelli, M.A.; Karl, D.W.; Kirby, E.P. 1987: Modification of the platelet-binding domain of von Willebrand factor Journal of Laboratory and Clinical Medicine 110(1): 113-118
Van Vliet, H.H.D.M.; Kappers-Klunne, M.C.; Leebeek, F.W.G.; Michiels, J.J. 2008: PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2 Thrombosis and Haemostasis 100(3): 462-468
Girma, J.P.; Pietu, G.; Lavergne, J.M.; Meyer, D.; Larrieu, M.J. 1982: Abnormal antigenic reactivity of factor VIII/von Willebrand factor subunit in variants of von Willebrand's disease Journal of Laboratory and Clinical Medicine 99(4): 481-494
Federici, A.B.; Canciani, M.T.; Forza, I.; Cozzi, G. 2000: Ristocetin cofactor and collagen binding activities normalized to antigen levels for a rapid diagnosis of type 2 von Willebrand disease--single center comparison of four different assays Thrombosis and Haemostasis 84(6): 1127-1128
Perret, B.A.; Furlan, M.; Jenö, P.; Beck, E.A. 1986: Von Willebrand factor-dependent agglutination of washed fixed human platelets by insoluble collagen isolated from bovine aorta Journal of Laboratory and Clinical Medicine 107(3): 244-252
Vaidyanathan, J.; Chinnaswamy, K.; Vaidyanathan, T.K. 2003: Biomimetic recognition and immunochemical assay of ligand binding to collagen Journal of Adhesive Dentistry 5(1): 7-17